Cerebrolysin evidence stronger in stroke than TBI, neuro-rehab review says
The porcine brain-derived peptide is used in roughly 50 countries but remains unlicensed in the US and UK, complicating patient conversations.
PR
By Priya Raman · Science Reporter
Sep 24 12:09 ETSource: London Post
The wire
- 01A neuro-rehabilitation piece summarises Cerebrolysin's evidence base: randomised trials combining it with standard rehab reported motor recovery gains in stroke, while dedicated traumatic brain injury data remain thinner.
- 02Clinicians increasingly field questions from patients who encounter peptide therapies via international treatment centres and private clinics, with expectations shaped by marketing rather than trial data.
- 03The article is a commentary, not new data, and names a research supplier; it notes reviews stop short of firm TBI conclusions and that sourcing and manufacturing standards vary widely.
From the source
Read at london-post.co.ukNeuroplasticity After Brain Injury: Why Peptide Signalling Is Becoming a Research Focus
Neuroplasticity, the brain’s capacity to rewire and reorganise itself after injury, sits at the heart of everything neuro-rehab does.
